The Application of Machine Learning Techniques in Clinical Drug Therapy

Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..

INTRODUCTION: The development of a novel drug is an extremely complicated process that includes the target identification, design and manufacture, and proper therapy of the novel drug, as well as drug dose selection, drug efficacy evaluation, and adverse drug reaction control. Due to the limited resources, high costs, long duration, and low hit-to-lead ratio in the development of pharmacogenetics and computer technology, machine learning techniques have assisted novel drug development and have gradually received more attention by researchers.

METHODS: According to current research, machine learning techniques are widely applied in the process of the discovery of new drugs and novel drug targets, the decision surrounding proper therapy and drug dose, and the prediction of drug efficacy and adverse drug reactions.

RESULTS AND CONCLUSION: In this article, we discussed the history, workflow, and advantages and disadvantages of machine learning techniques in the processes mentioned above. Although the advantages of machine learning techniques are fairly obvious, the application of machine learning techniques is currently limited. With further research, the application of machine techniques in drug development could be much more widespread and could potentially be one of the major methods used in drug development.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Current computer-aided drug design - 15(2019), 2 vom: 01., Seite 111-119

Sprache:

Englisch

Beteiligte Personen:

Meng, Huan-Yu [VerfasserIn]
Jin, Wan-Lin [VerfasserIn]
Yan, Cheng-Kai [VerfasserIn]
Yang, Huan [VerfasserIn]

Links:

Volltext

Themen:

Computer technology
Drug development
Drug efficacy
Journal Article
Machine learning technique
Noveldrug
Pharmacogenetics.
Review

Anmerkungen:

Date Completed 05.07.2019

Date Revised 05.07.2019

published: Print

Citation Status MEDLINE

doi:

10.2174/1573409914666180525124608

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM284500895